12/3
06:25 am
cvs
Rating for CVS
Low
Report
Rating for CVS
12/3
06:25 am
cvs
Rating for CVS
Low
Report
Rating for CVS
11/18
08:29 am
cvs
Rating for CVS
Low
Report
Rating for CVS
11/18
08:29 am
cvs
Rating for CVS
Low
Report
Rating for CVS
11/18
08:07 am
cvs
CVS Health Co. (NYSE: CVS) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $66.00 price target on the stock, up previously from $60.00.
Medium
Report
CVS Health Co. (NYSE: CVS) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $66.00 price target on the stock, up previously from $60.00.
11/15
12:24 pm
cvs
Rating for CVS
Low
Report
Rating for CVS
11/15
12:24 pm
cvs
Rating for CVS
Low
Report
Rating for CVS
11/7
11:00 am
cvs
Rating for CVS
Medium
Report
Rating for CVS
11/7
09:53 am
cvs
Rating for CVS
Medium
Report
Rating for CVS
11/7
09:53 am
cvs
Rating for CVS
Medium
Report
Rating for CVS
11/4
08:40 am
cvs
Rating for CVS
Low
Report
Rating for CVS
11/4
08:40 am
cvs
Rating for CVS
Low
Report
Rating for CVS
10/24
08:44 am
cvs
Rating for CVS
Low
Report
Rating for CVS
10/24
08:44 am
cvs
Rating for CVS
Low
Report
Rating for CVS
10/23
08:24 am
cvs
Rating for CVS
Low
Report
Rating for CVS
10/23
08:24 am
cvs
Rating for CVS
Low
Report
Rating for CVS
10/10
08:24 am
cvs
Rating for CVS
Low
Report
Rating for CVS
10/10
08:24 am
cvs
Rating for CVS
Low
Report
Rating for CVS
10/10
07:32 am
cvs
CVS Health Co. (NYSE: CVS) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $82.00 price target on the stock, up previously from $63.00.
Low
Report
CVS Health Co. (NYSE: CVS) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $82.00 price target on the stock, up previously from $63.00.
10/8
01:07 pm
cvs
Rating for CVS
Low
Report
Rating for CVS
10/1
11:17 am
cvs
CVS Health Co. (NYSE: CVS) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $62.00 price target on the stock.
Low
Report
CVS Health Co. (NYSE: CVS) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $62.00 price target on the stock.
10/1
10:54 am
cvs
Rating for CVS
Low
Report
Rating for CVS